Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Cyanopyridine >  4-Pyridinecarbonitrile,2-formyl-(9CI)

4-Pyridinecarbonitrile,2-formyl-(9CI)

Basic information Safety Supplier Related

4-Pyridinecarbonitrile,2-formyl-(9CI) Basic information

Product Name:
4-Pyridinecarbonitrile,2-formyl-(9CI)
Synonyms:
  • 4-Pyridinecarbonitrile,2-formyl-(9CI)
  • 4-Cyanopyridine-2-carboxaldehyde
  • 2-forMyl-4-pyridinecarbonitrile
  • 2-forMylisonicotinonitrile
  • 2-Formylpyridine-4-carbonitrile
  • 4-Cyano-2-pyridinecarboxaldehyde
  • 4-Pyridinecarbonitrile, 2-formyl-
  • 4-Pyridinecarbonitrile,2-formyl-(9CI) ISO 9001:2015 REACH
CAS:
116308-38-4
MF:
C7H4N2O
MW:
132.12
Product Categories:
  • PYRIDINE
Mol File:
116308-38-4.mol
More
Less

4-Pyridinecarbonitrile,2-formyl-(9CI) Chemical Properties

Boiling point:
201.0±20.0℃ (760 Torr)
Density 
1.24±0.1 g/cm3 (20 ºC 760 Torr)
Flash point:
75.4±21.8℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-0.45±0.10(Predicted)
Appearance
Light yellow to yellow Solid
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-43
Safety Statements 
36/37
More
Less

4-Pyridinecarbonitrile,2-formyl-(9CI) Usage And Synthesis

Synthesis

51454-63-8

116308-38-4

Oxalyl chloride (13.2 mL, 150 mmol) was dissolved in anhydrous dichloromethane (86 mL) under nitrogen protection and cooled to -78°C. Dimethyl sulfoxide (21.2 mL) was added slowly dropwise over 20 min and the reaction mixture was stirred at -78°C for 15 min. Subsequently, 4-cyanopyridine-2-methanol (4.0 g, 30 mmol) dissolved in anhydrous dichloromethane (60 mL) was added dropwise to the reaction mixture over a period of 5 min and stirring was continued for 2 h while maintaining -78°C and a nitrogen atmosphere. Formation of a white solid precipitate was observed during the reaction. The reaction temperature was raised to -55°C and triethylamine (6.15 mL, 450 mmol) was added dropwise over 15 minutes. The cooling bath was removed and the reaction mixture was allowed to warm naturally to room temperature over a period of 2 hours. Upon completion of the reaction, the mixture was diluted with dichloromethane (400 mL), washed successively with brine (2 x 50 mL), and the aqueous phase was then back-extracted with dichloromethane (3 x 50 mL). All organic layers were combined and concentrated under reduced pressure to give a light yellow solid product. The product did not require further purification and showed a single peak by LC-MS analysis with a retention time (RT) of 2.53 min and a mass spectrometry (M + H) peak located at m/z 133.0 in quantitative yield.

References

[1] Patent: WO2006/21801, 2006, A1. Location in patent: Page/Page column 65-66
[2] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[3] Patent: US6043248, 2000, A
[4] Patent: WO2006/21801, 2006, A1. Location in patent: Page/Page column 46-47
[5] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 559 - 576

4-Pyridinecarbonitrile,2-formyl-(9CI)Supplier

Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Email
sales@trio-pharmatech.com
Shanghai Synthfine Chemical Co.,Ltd
Tel
15921303235
Email
sales@synthfine.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
SynAsst Chemical.
Tel
021-60343070